Table 5 Crude cost estimate reported in transplanted and unspecified RRT patients:

 Li et al. [11, 22]

2015

Mean inpatient cost (₤)

None

3626 (3439, 3813)*

5921 (5499, 6343)*

63%

<0.0005

Mean outpatient cost (₤)

None

3963 (3890, 4036)*

4520 (4376, 4665)*

14%

<0.0005

 Salonen et al. [29]

2003

Mean cost 0–6 months (US$)

None

38,946

37,299

−4%

Mean cost 7–12 months (US$)

None

7216

8497

18%

Mean cost 2nd year (US$)

None

11,972

10,802

−10%

 Couillerot et al. [30]

2017

Mean monthly health care costs (euros) fort a stable prevalent patient

18–44 years

1043 (1188)

2091 (1998)

100%

45–69 years

1075 (1065)

1640 (1337)

53%

70+ years

1038 (888)

1475 (1129)

42%

 Ghoddousi et al. [35]

2007

Total cost (PPP $ rehospitalization)

None

863.93 (1165.2)

1261.98 (1930.5)

46%

 Smith et al. [36]

1989

Year of transplant annual charges LTRAN

None

41,553

46,797

13%

Year of transplant annual charges CTRAN

None

42,074

61,493

46%

Year of transplant annual charges FTRAN

None

58,672

63,670

9%

Year after transplant annual charges LTRAN

None

3836

4320

13%

Year after transplant annual charges CTRAN

None

5696

8325

46%

Year after transplant annual charges FTRAN

None

47,057

50,584

7%

 Woodward et al. [37]

2011

DM before transplant. Cumulative cost per patient from 3 years before transplant to 5 years after transplant

None

114,686

162,048

29%

NODAT before transplant. Cumulative cost per patient from 3 years before transplant to 5 years after transplant

None

114,686

146,915

22%

 Joyce et al. [32]

2004

Annual cost for the 12 months post onset of ESKD ($)

None

57,249

86,081

50%

 Wong et al. [34]

2012

Total costs ($)

45 years old

119,329

136,677

13%

Total costs ($)

60 years old

143,004.98

151,168.29

5%